These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 10363621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolic functions of the liver during chemotherapy in children with acute lymphoblastic leukemia.
    Wiela-Hojenska A, Gorczynska E, Orzechowska-Juzwenko K, Golebiowski W, Hurkacz M, Boguslawska-Jaworska J.
    Int J Clin Pharmacol Ther; 2001 Jun; 39(6):246-50. PubMed ID: 11430632
    [Abstract] [Full Text] [Related]

  • 3. [Biotransformation of phenazone and sulfadimidine as markers of liver metabolism of drug and xenobiotic oxidation and acetylation in women with breast cancer].
    Orzechowska-Juzwenko K, Wiela-Hojeńska A, Milejski P, Cieślińska A, Hudziec P, Adamska M.
    Przegl Lek; 1997 Jun; 54(2):103-6. PubMed ID: 9198818
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of disorders of thyroid function on phenazone pharmacokinetics].
    Bolanowski M, Orzechowska-Juzwenko K, Gruszka S, Szymczak J.
    Pol Tyg Lek; 1997 Jun; 45(6-7):136-9. PubMed ID: 2216953
    [Abstract] [Full Text] [Related]

  • 7. [An attempt at assessment of biotransformation activity in calves' liver on the basis of the rate of antipyrine elimination from saliva].
    Janus K, Baranow-Baranowski S, Jakubowska D.
    Pol Arch Weter; 1991 Jun; 31(3-4):65-71. PubMed ID: 1842615
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of the capacity of the liver for phenazone biotransformation in patients with uremia on peritoneal dialysis].
    Grzegorzewska A, Lowicki Z, Chmara E, Mrozikiewicz A, Baczyk K.
    Pol Tyg Lek; 1991 Jun; 45(16-18):339-41. PubMed ID: 2235722
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Pharmacokinetics of phenazone in patients with fast and slow euthyroidism after methimazole treatment].
    Wójcicki J, Górnik W, Syrenicz A, Gawrońska-Szklarz B, Czekalski S.
    Pol Tyg Lek; 1991 Jun; 45(6-7):131-3. PubMed ID: 2216952
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Changes in drug elimination under the influence of perazine therapy (author's transl)].
    Petruch F, Schüppel R, Breyer U.
    Arzneimittelforschung; 1976 Jun; 26(6):1154-5. PubMed ID: 9113
    [Abstract] [Full Text] [Related]

  • 13. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C, Hassan HT.
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [Abstract] [Full Text] [Related]

  • 14. [Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms].
    Wiela-Hojeńska A, Milejski P, Orzechowska-Juzwenko K, Usnarska-Zubkiewicz L, Urbaniak-Kujda D, Kotlarek-Haus S.
    Przegl Lek; 1997 Mar; 54(3):163-6. PubMed ID: 9297191
    [Abstract] [Full Text] [Related]

  • 15. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME, Ashirmetov AKh.
    Vopr Med Khim; 1985 Mar; 31(1):76-9. PubMed ID: 3984279
    [Abstract] [Full Text] [Related]

  • 16. Effect of schistosomiasis infection on the clearance of phenazone in mice.
    Metwally AA, Janku I, Kemper F, Khayyal MT, Ebeid FA, Botros SS.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):206-9. PubMed ID: 2110459
    [Abstract] [Full Text] [Related]

  • 17. Metabolic efficiency of the liver in patients with breast cancer as determined by pharmacokinetics of phenazone.
    Orzechowska-Juzwenko K, Wiela A, Cieślińska A, Roszkowska E.
    Cancer; 1987 May 01; 59(9):1607-10. PubMed ID: 3828961
    [Abstract] [Full Text] [Related]

  • 18. [Oxidative hepatic metabolism in chronic alcoholics during the acute abstinence period: evaluation with antipyrine elimination].
    Soto Alvarez J, Alsar Ortiz MJ.
    Rev Clin Esp; 1993 Jun 01; 193(2):60-3. PubMed ID: 8341815
    [Abstract] [Full Text] [Related]

  • 19. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
    Teunissen MW, van der Veen EA, Doodeman PJ, Breimer DD.
    Eur J Clin Pharmacol; 1984 Jun 01; 27(1):99-103. PubMed ID: 6489432
    [Abstract] [Full Text] [Related]

  • 20. [Effect of mestranol on pharmacokinetics of phenazone in the rabbit].
    Gawrońska-Szklarz B, Droździk M, Kwiatkowski A, Wójcicki J.
    Ginekol Pol; 1996 Jan 01; 67(1):1-6. PubMed ID: 8655012
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.